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Purpose To evaluate, in a controlled prospective manner with double-blind read,
whether there are differences in interpretations of PET/CT scans at our tertiary
medical centre, Rigshospitalet, compared to the external hospitals.
Methods Ninety consecutive patients referred to our department who had an exter-
nal F-18-FDG PET/CT scan were included. Only information that had been avail-
able at the time of the initial reading at the external hospital was available at
re-interpretation. Teams with one radiologist and one nuclear medicine physician
working side by side performed the re-interpretation in consensus. Two oncolo-
gists subsequently and independently compared the original reports with the
re-interpretation reports. In case of ‘major discordance’, the oncologists assessed
the respective reports validities.
Results The interpretations were graded as ‘accordant’ in 43 patients (48%), ‘minor
discordance’ in 30 patients (33%) and ‘major discordance’ in 17 patients (19%).
In 11 (65%) of the 17 cases graded as ‘major discordance’, it was possible to
determine which report that was most correct. In 9 of these 11 cases (82%), the
re-interpretation was most correct; in one case, the original report and in another
case, both interpretations were incorrect.
Conclusions Major discordant interpretations were frequent [19% (17 of 90 cases)].
In those cases where follow-up could assess the validity, the re-interpretation at
Rigshospitalet was most correct in 9 of 11 cases (82%), indicating that there is a
difference in expertise in interpreting PET/CT at a tertiary referral hospital
compared to primary local hospitals.
Introduction
Patients referred to our tertiary care medical centre for treat-
ment frequently present with imaging studies that were
obtained elsewhere, and the referring physicians or surgeons
often request an ‘in-house’ interpretation of these ‘outside’
imaging studies.
At our Department of Clinical Physiology, Nuclear Medicine
and PET at Rigshospitalet, these ‘in-house’ interpretations or
re-interpretations of outside PET/CT scans are named ‘second
opinions’. When a ‘second opinion’ is requested, the images
are required including a copy of the initial local report to
ensure that no finding mentioned in the initial report is
overlooked in our re-interpretation. Second opinions are typi-
cally requested before surgery in patients with lung cancer,
mesothelioma, gynaecological tumours, liver tumours and
prior to treatment of lymphoma. We have noted important
differences in the in-house and outside image interpretations,
and therefore, we initiated this study.
First we compared 159 clinical re-interpretations of external
PET/CT scans to the original reports and found ‘major discor-
dance’ in 26% of the cases (unpublished data), and we evalu-
ated our in-centre interobserver agreement on 100 internal
PET/CT scans and found ‘major discordance’ in only 5% of
the cases (unpublished data). Then, we decided to evaluate this
properly, as the results of this open analysis were important
and controversial, and our initial open non-blinded methodol-
ogy could be criticized. The importance was also warranted by
the fact there are no reports in the literature on second
opinions on PET/CT.
The aim of this study was to evaluate in a controlled
prospective manner with double-blind read whether there are
differences in PET/CT image interpretations of PET/CT scans
at our tertiary medical centre, Rigshospitalet, compared to the
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external hospitals. We used the same original images and the
same clinical information, and we did not use the initial PET/
CT interpretation for our in-house interpretation. Histopatho-
logic analysis, surgical findings and clinical follow-up served
as standard of reference.
Materials and methods
Patients
From March 2012 through June 2012, 90 consecutive patients
referred to our department who had an external F-18 fluoro-
deoxy-glucose (FDG) PET/CT scan were included in this
study. Patients from abroad were excluded due to follow-up
issues. The local ethics committee classified the study as
Quality Control & Quality Assurance and therefore waived the
requirement for informed consent.
The characteristics of the study population regarding indica-
tions for referral are summarized in Table 1. This material
reflects the heterogeneity in our clinical practice. The study
population included patients with malignancy or suspicion of
malignancy in all but three cases where the indication for
referral was infection (N = 2) and sarcoidosis (N = 1). The
most frequent malignancy was colorectal cancer (N = 23).
The mean age of the patients was 65 years (range 24–91 years).
The PET/CT scans had been performed at nine different hospi-
tals in Denmark, with 28 studies performed at a nearby hospital
and only one study from the two most distant hospitals.
Seventeen PET/CT scans (19%) were performed only with low-
dose CT and the remaining 73 (81%) were PET/CT scans with
diagnostic CT quality, and the vast majority of the scans were
contrast enhanced.
Study design
In the daily clinical routine, a copy of the original PET/CT
report is always available to our nuclear medicine physicians
and radiologists at the time of re-interpretation of the scan to
ensure that no finding noted in the initial report is over-
looked. Sometimes, histopathology, pertinent imaging or
clinical data are also available. To avoid this information bias
in our study, we engaged an independent medical student,
hereafter called data controller (DC). The DC made sure that
only the information that had been available at the time of
the original interpretation at the external hospital was available
at our re-interpretation. This included the removal of the
original report and all information that was not available
when the original report had been performed. The DC also
made sure that the nuclear medicine physician and radiologist
doing the re-interpretations had not been involved in the
previous clinical re-interpretation of the scan.
PET/CT image interpretations
Teams with one radiologist and one nuclear medicine physi-
cian working side by side, all experienced in reporting PET/
CT scans, performed the re-interpretation in consensus, identi-
cal with our daily routine clinical practice. In total, five
nuclear medicine physicians with a minimum of 5 years of
experience of PET/CT reporting and five radiologists were
involved in the reporting (Our department performs 7000
PET/CT studies annually). The nuclear medicine physician
viewed the cases with TrueD software on a Leonardo worksta-
tion (Siemens, Forchheim, Germany), while the radiologist
used an Agfa Impax 5.2 (Agfa-Gevaert NV, Mortsel, Belgium)
PACS client.
Patient diagnosis
Two oncologists and in selected cases also a clinician within
another relevant specialty subsequently and independently
compared the original reports with the reinterpretation reports
and graded these as ‘accordant’, ‘minor discordance’ or ‘major
discordance’. ‘Major discordance’ was defined as findings
which would affect clinical management. For example, a lung
lesion initially interpreted as benign but re-interpreted as
highly suspicious for lung metastasis (Fig. 1). ‘Minor
discordance’ included findings unlikely to alter patient care or
irrelevant for the further clinical course, for example, when
an adrenal metastasis is overseen in a patient with dissemi-
nated disease (Fig. 2). In case of ‘major discordance’ between
the original report and the re-interpretation, the oncologists
assessed the respective reports validities by obtaining histo-
logic analysis of tissue obtained from biopsy or surgery,
surgical findings, consequent imaging studies and clinical
follow-up. Mean follow-up time was 588 days.
All cases were part of our clinical routine for ‘second opin-
ions’, and therefore, a final re-interpretation was performed
Table 1 Indication for referral versus accordance/discordance.
Indication for referral Accordant
Discordance
TotalMinor Major
Colorectal cancer 14 6 3 23
Malignancy? 5 7 2 14
Lung cancer 5 2 3 10
Sarcoma 5 1 2 8
Mesothelioma 3 1 1 5
Lymphoma 1 1 2 4
Pancreatic cancer 1 2 – 3
Cancer of unknown
primary origin
1 1 1 3
Renal cancer 1 2 – 3
Infection 1 1 – 2
Head and neck cancer 1 1 – 2
Oesophageal cancer 1 – 1 2
Cervical cancer – 1 1 2
Othera 4 4 1 9
Sum 43 30 17 90
aIncludes one patient each with ovarian cancer, prostate cancer, hepa-
tic cancer, small intestine cancer, cholangiocarcinoma, breast cancer,
melanoma, gastric cancer and sarcoidosis.
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using all relevant clinical information and the initial PET/CT
report to secure the patient an optimal treatment. These final
‘official’ re-interpretations were given to the clinicians and
were the basis for the actual clinical management and were
not part of this study.
Exact binomial 95% confidence intervals (CIs) were used to
evaluate the reliability of the rates of change.
Results
When the initial external reports were compared with the
re-interpretation reports, 43 (48%) of the 90 cases (95% CI:
37–59%) were graded as ‘accordant’. There was a ‘minor dis-
cordance’ in interpretation in 30 (33%) cases (95% CI:
24–44%) unlikely to alter patient care or irrelevant for the
further clinical course. In 17 (19%) of the cases (95% CI:
11–29%), there was a ‘major discordance’ which would result
in a significant change in clinical management, Table 1.
Among the 17 cases, in which ‘major discordance’
occurred, the following diagnoses were the most common;
pulmonary cancer (3), colorectal cancer (3), sarcoma (2) and
lymphoma (2). In 11 (65%) of the 17 cases graded as ‘major
discordance’, it was possible, after reviewing clinical informa-
tion including operation descriptions, pathology report,
subsequent imaging studies and clinical follow-up, to deter-
mine which report that was most correct. In six cases, this
was not possible to determine; four patients died within less
than 4 months postscan date, one patient had no operation or
biopsy due to subsequent dissemination to other sites, and for
one patient, histopathology report was inconclusive, and no
additional biopsy was performed. Results from those 11 cases
where it were possible to determine which report that was
most correct are summarized in Table 2. In 9 of the 11 cases
(82%), the re-interpretation was most correct, and in one case
(9%), the original report was most accurate. In the last one
case (9%), both interpretations were incorrect, meaning that
both differed significantly from the final diagnosis.
Discussion
In tertiary referral hospitals, official re-interpretations of
externally obtained imaging studies are common within both
radiology and nuclear medicine to reduce rate of repeat imag-
ing (Lu & Tellis, 2012). At Rigshospitalet, a tertiary referral
hospital in Copenhagen, Denmark, re-interpreting of PET/CT
scans (i.e. second opinion) is typically required in the context
of a multidisciplinary team meeting. Frequently, the change in
interpretation in this setting results in a change of patient
management.
In the literature, we have not found any study of second
opinions on PET/CT, but there are several studies on the
difference between the original report and second opinion in
radiology. G. J. Loughrey found a major difference in inter-
pretation in 34% of 536 CT and MRI scans, which was
assessed by an oncology specialist radiologist (Loughrey et al.,
1999). Specialist radiology review changed radiological
staging in 19% of cases. Loevner et al. (2002) assessed the
clinical value of re-interpreting cross-sectional imaging studies
of patients with head and neck cancer, in the setting of a
multidisciplinary cancer centre. One hundred and thirty-six
patients’ CT and MRI scans were re-interpreted by a neurora-
diologist. In 56 (41%) cases, there was a change in interpreta-
tion, which ultimately altered treatment in 55 (40%). Another
study on second-opinion consultations in neuroradiology
found a 77% rate of clinically important discrepant interpreta-
tions (347 of 4534 studies) (Zan et al., 2010). When a defini-
tive diagnosis was obtainable, the second-opinion consultation
was more accurate in 84% of studies. A study on 773 second-
opinion interpretations by specialty radiologists at a tertiary
care children’s hospital in an unselected paediatric population
Figure 1 Positron emission tomography/CT shows a lung lesion
(arrow) in a 30-year-old female patient surgically treated for sarcoma.
The lung lesion was initially interpreted as benign but re-interpreted
as highly suspicious for lung metastasis. Subsequent imaging and clin-
ical follow-up confirmed that the lesion represents a lung metastasis.
Figure 2 Positron emission tomography/CT shows a metastasis to
the right adrenal gland (arrow) in addition to multiple lung and bone
metastases in a 72-year-old female patient 5 years after radical surgery
for colorectal cancer. The metastasis to the right adrenal gland was
overseen at the initial report, but this had no influence on this
patient’s further clinical course.
© 2015 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd on behalf of Scandinavian Society of
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noted major disagreement rates of 143% and 326% for
neurologic and body examinations, respectively (Eakins et al.,
2012).
Gollub et al. (1999) studied the clinical importance of
re-interpretation of 143 CT scans obtained elsewhere on cancer
patients referred for care at a tertiary cancer centre. They found
‘major disagreement’ in 24 patients (17%) and ‘minor disagree-
ment’ in 29 patients (20%), and these results are consistent with
ours. These studies are example of studies in which investigators
have shown that re-interpretation of imaging studies by
subspecialized radiologists can affect staging, management and
potentially the prognosis in cancer patients.
In some of these studies, the original report had been
available to the radiologist at the time for re-interpretation and,
in many instances, the initial readings were likely reported with-
out the benefit of the complete clinical history and sometimes
newer findings on physical examination, including results from
more recent histopathology reports. In this study, we investi-
gated whether there are differences in expertise in interpreting
PET/CT at a tertiary referral hospital compared to outside
hospitals by removing all information bias, that is the same
clinical information was available to the radiologist and nuclear
physician as it was at the time for the initial reading.
Although we did not find any studies of second opinions
on PET/CT, there are a few on interobserver variability.
Hofman et al. (2009) examined the interobserver variability of
PET/CT for staging of lymphoma and found that experienced
observers at a centre in London had a high level of agreement
using PET/CT for lymphoma staging. In another study by
Barrington et al. (2010), four PET centres in Europe (including
Rigshospitalet in Copenhagen) participated in an evaluation of
PET/CT scans of 50 patients with Hodgkin’s lymphoma before
and after two cycles of chemotherapy. The scans were
reported using a five-point scale to score the remaining activ-
ity. When score 1–2 was classify as ‘negative’ and 3–5 as
‘positive’, Barrington et al., found an agreement in 44 of the
50 patients (88%) at all four centres.
Our analysis has shown a difference in the quality of the
PET/CT interpretations between the primary hospital and
Rigshospitalet in Copenhagen with the same clinical informa-
tion available. In 19% of cases, we noted a ‘major discor-
dance’ meaning a discrepancy of a magnitude that would
significantly affect clinical management. We find this surpris-
ingly high. This figure could be compared to the results from
the National Oncologic PET Registry (NOPR), which overall
showed that physicians changed their intended management
in 365% (95% CI, 359–372) of cases after PET (Hillner
et al., 2008). An important cornerstone for ordering a diag-
nostic scan must be that the patients and the treating physi-
cians could be certain that the interpretation of a PET/CT is
correct, independent of where it has been undertaken.
The fact that the re-interpretation at Rigshospitalet was most
correct in 82% of the cases where it could be determined,
excluding six cases where it could not, and that only one case
(9%) showed the original report to be most correct, indicates
that quality improvements should be considered, with special
focus on departments who have problems with the validity of
their PET/CT interpretations.
There are a few limitation of our study to generally apply
these results to all PET/CT reports. First, only reports in which
an official second opinion was requested were included mean-
ing that in most cases there had been significant and relevant
findings in the original report. Therefore, the discrepancy rates
may be higher than if the study had included all PET/CT
reports. Second, reports from nine outside hospitals with very
varying experience both in throughput and years of perform-
ing PET/CT were included. For example, one hospital only
had a 1-year experience with PET/CT and performed at the
time of the study less than 1000 scans annually. At Rigshospi-
talet, all readers in this study had a minimum of 5 years of
experience of PET/CT reporting. The individual readers’
experience at the outside hospitals, which most probably
influences the quality of the reports, is not investigated due to
the number of readers.
The higher rate of correct interpretations at Rigshospitalet is
probably due to a combination of close contact between clini-
cians and nuclear medicine physicians/radiologists through
multidisciplinary team meetings and research, in addition to
the high level of competence and throughput with more than
7000 PET scans a year for several years. At most Danish hospi-
tals, PET/CT scans are read by a team consisting of a nuclear
medicine physician and a radiologist, but often this dual read-
ing is performed first separately and then a consensus is
formulated. At Rigshospitalet, the team read simultaneously,
Table 2 Cases with ‘major discordance’ where it was possible to
determine which report was deemed most correct.
Indication for
referral Verification
Report most
correct
Cervical cancer Clinical follow-up,
histopathology report,
subsequent imaging
Re-interpretation
Lung cancer Clinical follow-up,
histopathology report
Re-interpretation
Lung cancer surgical findings,
histopathology report
Re-interpretation
Lung cancer Histopathology report Re-interpretation
Colorectal cancer Histopathology report,
subsequent imaging
Re-interpretation
Malignancy? Surgical findings,
histopathology report,
subsequent imaging
Re-interpretation
Mesothelioma Clinical follow-up,
histopathology report
Re-interpretation
Sarcoma Clinical follow-up,
subsequent imaging
Re-interpretation
Lymphoma Histopathology report Re-interpretation
Lymphoma Histopathology report Both wrong
UPT Clinical follow-up,
subsequent imaging
Original report
UPT, unknown primary tumour.
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and it is possible that this better facilitates the discussion and
knowledge exchange within the team. At the same time, up to
three teams can be working side by side in the same reading
room which makes expertise easy accessible for discussion.
We also believe that our everyday case discussions could influ-
ence on the quality. This scenario is not always possible to set
up in a hospital with few scans and readers.
Although there has been a tradition of attending Rigshospi-
talet before starting with PET/CT, we see this study as an
argument for setting up a continuing educational system with
focus on PET/CT interpretation of common diagnoses.
After this study was performed, there has been taken an
initiative to harmonize PET/CT reporting in Denmark. In addi-
tion to this, all hospitals in the region are in 2015–2016
implementing a mutual regional PACS (picture archiving and
communication system), simplifying access to images and
reports. This study has encouraged us to advocate for routine
feedback to the outside hospitals, and a mutual regional PACS
makes this feasible.
Conclusion
In this study of 90 PET/CT scans performed at external hospi-
tals, we found major discordance in 19% of cases when
re-interpreted at Rigshospitalet, a tertiary referral hospital. The
reinterpretations were performed without knowledge of the
findings reported in the initial local readings or any other
information not available at the time of the initial reading.
Discordances were frequently seen in patients with lung can-
cer, colorectal cancer and sarcoma. Clinical follow-up showed
that when there was major discordance, the re-interpretation
at Rigshospitalet was most correct in 82%, indicating that
there is a difference in expertise in interpreting PET/CT at a
tertiary referral hospital compared to primary local hospitals.
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